- Home
- TACT vs AEON Comparison
TACT vs AEON Comparison
Compare TACT & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACT
- AEON
- Stock Information
- Founded
- TACT 1996
- AEON N/A
- Country
- TACT United States
- AEON United States
- Employees
- TACT N/A
- AEON N/A
- Industry
- TACT Computer peripheral equipment
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- TACT Technology
- AEON Health Care
- Exchange
- TACT Nasdaq
- AEON Nasdaq
- Market Cap
- TACT 40.4M
- AEON 36.4M
- IPO Year
- TACT 1996
- AEON N/A
- Fundamental
- Price
- TACT $3.93
- AEON $0.56
- Analyst Decision
- TACT Strong Buy
- AEON Strong Buy
- Analyst Count
- TACT 1
- AEON 1
- Target Price
- TACT $7.50
- AEON $5.00
- AVG Volume (30 Days)
- TACT 24.3K
- AEON 111.7K
- Earning Date
- TACT 11-07-2024
- AEON 11-13-2024
- Dividend Yield
- TACT N/A
- AEON N/A
- EPS Growth
- TACT N/A
- AEON N/A
- EPS
- TACT N/A
- AEON N/A
- Revenue
- TACT $46,418,000.00
- AEON N/A
- Revenue This Year
- TACT N/A
- AEON N/A
- Revenue Next Year
- TACT $22.65
- AEON N/A
- P/E Ratio
- TACT N/A
- AEON N/A
- Revenue Growth
- TACT N/A
- AEON N/A
- 52 Week Low
- TACT $3.32
- AEON $0.55
- 52 Week High
- TACT $7.97
- AEON $17.17
- Technical
- Relative Strength Index (RSI)
- TACT 39.62
- AEON 25.60
- Support Level
- TACT $3.81
- AEON $0.65
- Resistance Level
- TACT $4.14
- AEON $0.88
- Average True Range (ATR)
- TACT 0.18
- AEON 0.07
- MACD
- TACT -0.01
- AEON -0.02
- Stochastic Oscillator
- TACT 26.85
- AEON 0.27
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.